| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.4 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.16 | 0.4 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.051 | 0.4 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.039 | 0.4 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |